Aspirin and Hemocompatibility Events With a Left Ventricular

This randomized clinical trial examines the safety of the exclusion of aspirin as part of an antithrombotic regimen including a vitamin K antagonist with a full

Related Keywords

Willebrand , Nordrhein Westfalen , Germany , Werfen , Kazakhstan , Boston , Massachusetts , United States , Canada , Berlin , Italy , Australia , United Kingdom , Czech Republic , France , Austria , Michigan , America , Mandeepr Mehra , , Bristol Myers Squibb , Astrazeneca , Pagani , Abbott Inc , Medtronic , University Of Michigan , Vascular Center , Almac Group , Abiomed , Us Bureau Of Labor Statistics , Novartis , Pfizer , Group Information , Heartware Ventricular Assist Device , Antiplatelet Removal , Hemocompatibility Events With , North America , End Point , Secondary End Point , Bend Points , Labor Statistics , Level Questionnaire , Aspirin Effect , Size Assessment , Survival Free , Nonsurgical Bleeding Events , Hospital Heart , Advanced Heart Disease , Drs Mehra , Interest Disclosures , Berlin Heart , Abbott Training , Zoll Circulation ,